cyc 202 has been researched along with longdaysin in 2 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (longdaysin) | Trials (longdaysin) | Recent Studies (post-2010) (longdaysin) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 8 | 0 | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirota, T; Honma, KI; Honma, S; Kay, SA; Lee, JW; Ono, D; Park, K | 1 |
| Encheva, V; Heesom, KJ; Lach, R; Ray, S; Reddy, AB; Snijders, AP; Valekunja, UK | 1 |
2 other study(ies) available for cyc 202 and longdaysin
| Article | Year |
|---|---|
Chemical Control of Mammalian Circadian Behavior through Dual Inhibition of Casein Kinase Iα and δ.
Topics: Adenine; Animals; Binding Sites; Casein Kinase Ialpha; Circadian Rhythm; Drug Design; Enzyme Inhibitors; Humans; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding | 2019 |
Phenotypic proteomic profiling identifies a landscape of targets for circadian clock-modulating compounds.
Topics: Adenine; Anthracenes; Cell Line, Tumor; Circadian Clocks; Circadian Rhythm; Drug Evaluation, Preclinical; Humans; Phenotype; Phosphorylation; Proteomics; Purines; Roscovitine; Signal Transduction; Transcription Factors | 2019 |